Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.
Identifieur interne : 001415 ( Main/Exploration ); précédent : 001414; suivant : 001416Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.
Auteurs : Luca G. Campana [Italie] ; Sara Valpione [Italie] ; Annalisa Tosi [Italie] ; Marco Rastrelli [Italie] ; Carlo R. Rossi [Italie] ; Camillo Aliberti [Italie]Source :
- Journal of vascular and interventional radiology : JVIR [ 1535-7732 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Antinéoplasiques (administration et posologie), Bléomycine (administration et posologie), Facteur de nécrose tumorale alpha (administration et posologie), Facteurs temps, Femelle, Humains, Hémangiosarcome (), Hémangiosarcome (anatomopathologie), Hémangiosarcome (diagnostic), Lymphangiosarcome (), Lymphangiosarcome (anatomopathologie), Lymphangiosarcome (diagnostic), Melphalan (administration et posologie), Perfusion (), Récidive tumorale locale, Résultat thérapeutique, Électrochimiothérapie.
- MESH :
- administration et posologie : Antinéoplasiques, Bléomycine, Facteur de nécrose tumorale alpha, Melphalan.
- anatomopathologie : Hémangiosarcome, Lymphangiosarcome.
- diagnostic : Hémangiosarcome, Lymphangiosarcome.
- Adulte d'âge moyen, Facteurs temps, Femelle, Humains, Hémangiosarcome, Lymphangiosarcome, Perfusion, Récidive tumorale locale, Résultat thérapeutique, Électrochimiothérapie.
English descriptors
- KwdEn :
- Antineoplastic Agents (administration & dosage), Bleomycin (administration & dosage), Electrochemotherapy, Female, Hemangiosarcoma (diagnosis), Hemangiosarcoma (pathology), Hemangiosarcoma (therapy), Humans, Lymphangiosarcoma (diagnosis), Lymphangiosarcoma (pathology), Lymphangiosarcoma (therapy), Melphalan (administration & dosage), Middle Aged, Neoplasm Recurrence, Local, Perfusion (methods), Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha (administration & dosage).
- MESH :
- chemical , administration & dosage : Antineoplastic Agents, Bleomycin, Melphalan, Tumor Necrosis Factor-alpha.
- diagnosis : Hemangiosarcoma, Lymphangiosarcoma.
- methods : Perfusion.
- pathology : Hemangiosarcoma, Lymphangiosarcoma.
- therapy : Hemangiosarcoma, Lymphangiosarcoma.
- Electrochemotherapy, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Time Factors, Treatment Outcome.
DOI: 10.1016/j.jvir.2015.11.060
PubMed: 26916941
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000984
- to stream PubMed, to step Curation: 000984
- to stream PubMed, to step Checkpoint: 000984
- to stream Ncbi, to step Merge: 007F36
- to stream Ncbi, to step Curation: 007F36
- to stream Ncbi, to step Checkpoint: 007F36
- to stream Main, to step Merge: 001417
- to stream Main, to step Curation: 001415
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.</title><author><name sortKey="Campana, Luca G" sort="Campana, Luca G" uniqKey="Campana L" first="Luca G" last="Campana">Luca G. Campana</name><affiliation wicri:level="1"><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Valpione, Sara" sort="Valpione, Sara" uniqKey="Valpione S" first="Sara" last="Valpione">Sara Valpione</name><affiliation wicri:level="1"><nlm:affiliation>Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Tosi, Annalisa" sort="Tosi, Annalisa" uniqKey="Tosi A" first="Annalisa" last="Tosi">Annalisa Tosi</name><affiliation wicri:level="1"><nlm:affiliation>Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Rastrelli, Marco" sort="Rastrelli, Marco" uniqKey="Rastrelli M" first="Marco" last="Rastrelli">Marco Rastrelli</name><affiliation wicri:level="1"><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Rossi, Carlo R" sort="Rossi, Carlo R" uniqKey="Rossi C" first="Carlo R" last="Rossi">Carlo R. Rossi</name><affiliation wicri:level="1"><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Aliberti, Camillo" sort="Aliberti, Camillo" uniqKey="Aliberti C" first="Camillo" last="Aliberti">Camillo Aliberti</name><affiliation wicri:level="1"><nlm:affiliation>Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26916941</idno><idno type="pmid">26916941</idno><idno type="doi">10.1016/j.jvir.2015.11.060</idno><idno type="wicri:Area/PubMed/Corpus">000984</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000984</idno><idno type="wicri:Area/PubMed/Curation">000984</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000984</idno><idno type="wicri:Area/PubMed/Checkpoint">000984</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000984</idno><idno type="wicri:Area/Ncbi/Merge">007F36</idno><idno type="wicri:Area/Ncbi/Curation">007F36</idno><idno type="wicri:Area/Ncbi/Checkpoint">007F36</idno><idno type="wicri:Area/Main/Merge">001417</idno><idno type="wicri:Area/Main/Curation">001415</idno><idno type="wicri:Area/Main/Exploration">001415</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.</title><author><name sortKey="Campana, Luca G" sort="Campana, Luca G" uniqKey="Campana L" first="Luca G" last="Campana">Luca G. Campana</name><affiliation wicri:level="1"><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Valpione, Sara" sort="Valpione, Sara" uniqKey="Valpione S" first="Sara" last="Valpione">Sara Valpione</name><affiliation wicri:level="1"><nlm:affiliation>Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Melanoma and Esophageal Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Tosi, Annalisa" sort="Tosi, Annalisa" uniqKey="Tosi A" first="Annalisa" last="Tosi">Annalisa Tosi</name><affiliation wicri:level="1"><nlm:affiliation>Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Melanoma and Sarcoma Pathology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Rastrelli, Marco" sort="Rastrelli, Marco" uniqKey="Rastrelli M" first="Marco" last="Rastrelli">Marco Rastrelli</name><affiliation wicri:level="1"><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Rossi, Carlo R" sort="Rossi, Carlo R" uniqKey="Rossi C" first="Carlo R" last="Rossi">Carlo R. Rossi</name><affiliation wicri:level="1"><nlm:affiliation>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Surgical Oncology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author><author><name sortKey="Aliberti, Camillo" sort="Aliberti, Camillo" uniqKey="Aliberti C" first="Camillo" last="Aliberti">Camillo Aliberti</name><affiliation wicri:level="1"><nlm:affiliation>Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Interventional Radiology Unit, Veneto Region Oncology Research Institute IOV-IRCCS, Via Gattamelata, 64, Padova 35128</wicri:regionArea><wicri:noRegion>Padova 35128</wicri:noRegion></affiliation></author></analytic><series><title level="j">Journal of vascular and interventional radiology : JVIR</title><idno type="eISSN">1535-7732</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antineoplastic Agents (administration & dosage)</term><term>Bleomycin (administration & dosage)</term><term>Electrochemotherapy</term><term>Female</term><term>Hemangiosarcoma (diagnosis)</term><term>Hemangiosarcoma (pathology)</term><term>Hemangiosarcoma (therapy)</term><term>Humans</term><term>Lymphangiosarcoma (diagnosis)</term><term>Lymphangiosarcoma (pathology)</term><term>Lymphangiosarcoma (therapy)</term><term>Melphalan (administration & dosage)</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Perfusion (methods)</term><term>Time Factors</term><term>Treatment Outcome</term><term>Tumor Necrosis Factor-alpha (administration & dosage)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Antinéoplasiques (administration et posologie)</term><term>Bléomycine (administration et posologie)</term><term>Facteur de nécrose tumorale alpha (administration et posologie)</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Hémangiosarcome ()</term><term>Hémangiosarcome (anatomopathologie)</term><term>Hémangiosarcome (diagnostic)</term><term>Lymphangiosarcome ()</term><term>Lymphangiosarcome (anatomopathologie)</term><term>Lymphangiosarcome (diagnostic)</term><term>Melphalan (administration et posologie)</term><term>Perfusion ()</term><term>Récidive tumorale locale</term><term>Résultat thérapeutique</term><term>Électrochimiothérapie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antineoplastic Agents</term><term>Bleomycin</term><term>Melphalan</term><term>Tumor Necrosis Factor-alpha</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antinéoplasiques</term><term>Bléomycine</term><term>Facteur de nécrose tumorale alpha</term><term>Melphalan</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Hémangiosarcome</term><term>Lymphangiosarcome</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemangiosarcoma</term><term>Lymphangiosarcoma</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Hémangiosarcome</term><term>Lymphangiosarcome</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Perfusion</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Hemangiosarcoma</term><term>Lymphangiosarcoma</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hemangiosarcoma</term><term>Lymphangiosarcoma</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Electrochemotherapy</term><term>Female</term><term>Humans</term><term>Middle Aged</term><term>Neoplasm Recurrence, Local</term><term>Time Factors</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Facteurs temps</term><term>Femelle</term><term>Humains</term><term>Hémangiosarcome</term><term>Lymphangiosarcome</term><term>Perfusion</term><term>Récidive tumorale locale</term><term>Résultat thérapeutique</term><term>Électrochimiothérapie</term></keywords></textClass></profileDesc></teiHeader></TEI><affiliations><list><country><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Campana, Luca G" sort="Campana, Luca G" uniqKey="Campana L" first="Luca G" last="Campana">Luca G. Campana</name></noRegion><name sortKey="Aliberti, Camillo" sort="Aliberti, Camillo" uniqKey="Aliberti C" first="Camillo" last="Aliberti">Camillo Aliberti</name><name sortKey="Rastrelli, Marco" sort="Rastrelli, Marco" uniqKey="Rastrelli M" first="Marco" last="Rastrelli">Marco Rastrelli</name><name sortKey="Rossi, Carlo R" sort="Rossi, Carlo R" uniqKey="Rossi C" first="Carlo R" last="Rossi">Carlo R. Rossi</name><name sortKey="Tosi, Annalisa" sort="Tosi, Annalisa" uniqKey="Tosi A" first="Annalisa" last="Tosi">Annalisa Tosi</name><name sortKey="Valpione, Sara" sort="Valpione, Sara" uniqKey="Valpione S" first="Sara" last="Valpione">Sara Valpione</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001415 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001415 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26916941
|texte= Angiosarcoma on Lymphedema (Stewart-Treves Syndrome): A 12-Year Follow-up after Isolated Limb Perfusion, Limb Infusion, and Electrochemotherapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26916941" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |